Entrada Therapeutics, Inc. Operating Lease, Liability, Current
Financial Statements › Balance Sheet › Liabilities › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-08-05
- 2026-06-30: Operating Lease, Liability, Current $4.45M.
- 2026-03-31: Operating Lease, Liability, Current $4.28M.
- 2025-12-31: Operating Lease, Liability, Current $4.14M.
- 2025-09-30: Operating Lease, Liability, Current $4.35M.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2026-06-30 | $4.45M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $4.28M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $4.14M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $4.35M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $5.46M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $6.51M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $7.56M 10-K · filed 2026-02-26 |
| 2024-09-30 | $7.74M 10-Q · filed 2024-11-05 |
| 2024-06-30 | $8.57M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $8.30M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $7.91M 10-K · filed 2025-02-27 |
| 2023-09-30 | $6.64M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $7.41M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $7.10M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $8.41M 10-K · filed 2024-03-13 |
| 2022-09-30 | $8.26M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $8.11M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $7.97M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-06 |